Literature DB >> 12681480

Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3.

K Vinod Vijayan1, Trevor C Huang, Yan Liu, Aubrey Bernardo, Jing Fei Dong, Pascal J Goldschmidt-Clermont, B Rita Alevriadou, Paul F Bray.   

Abstract

Adhesion of platelets to the exposed extracellular matrix proteins at sites of vascular injury is partly regulated by the local fluid shear stress. Because the Leu33Pro (Pl(A)) polymorphism of integrin beta(3) confers only a modest increase in adhesion under static conditions, we used CHO and 293 cells expressing the Leu33 or Pro33 isoform of beta(3) in flow chamber experiments to test whether shear forces would alter the Pl(A) adhesive phenotype. We found that shear force augmented the Pro33-mediated enhanced adhesion to fibrinogen. This Pro33-dependent enhancement was aspirin-sensitive and was also observed on immobilized von Willebrand factor and cryoprecipitate, but not fibronectin. Thus, shear stress enhances the adhesive phenotype of the Pro33 cells to multiple physiologic substrates. Copyright 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681480     DOI: 10.1016/s0014-5793(03)00170-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.

Authors:  Christopher N Floyd; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

2.  Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow.

Authors:  Li Wang; Jiang-Yun Luo; Bochuan Li; Xiao Yu Tian; Li-Jing Chen; Yuhong Huang; Jian Liu; Dan Deng; Chi Wai Lau; Song Wan; Ding Ai; King-Lun Kingston Mak; Ka Kui Tong; Kin Ming Kwan; Nanping Wang; Jeng-Jiann Chiu; Yi Zhu; Yu Huang
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

3.  The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.

Authors:  Michael R Dohn; Christopher G Kooker; Lisa Bastarache; Tammy Jessen; Capria Rinaldi; Seth Varney; Matthew D Mazalouskas; Hope Pan; Kendra H Oliver; Digna R Velez Edwards; James S Sutcliffe; Joshua C Denny; Ana M D Carneiro
Journal:  J Neurosci       Date:  2017-10-16       Impact factor: 6.167

4.  Structure of an extended β3 integrin.

Authors:  Dongwen Zhou; Aye Myat Myat Thinn; Yan Zhao; Zhengli Wang; Jieqing Zhu
Journal:  Blood       Date:  2018-07-17       Impact factor: 22.113

5.  Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606.

Authors:  Kendra H Oliver; Tammy Jessen; Emily L Crawford; Chang Y Chung; James S Sutcliffe; Ana M Carneiro
Journal:  Mol Pharmacol       Date:  2014-04-02       Impact factor: 4.436

6.  HPA-1 polymorphism of alphaIIbbeta3 modulates platelet adhesion onto immobilized fibrinogen in an in-vitro flow system.

Authors:  Robert Loncar; Volker Stoldt; Sabine Hellmig; Rainer B Zotz; Mario Mihalj; Rüdiger E Scharf
Journal:  Thromb J       Date:  2007-02-19

Review 7.  The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis.

Authors:  Christopher N Floyd; Benjamin H Ellis; Albert Ferro
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function.

Authors:  Christopher N Floyd; Albert Ferro; Timothy D Warner
Journal:  JRSM Cardiovasc Dis       Date:  2015-11-03

9.  Inhibition of αIIbβ3 Ligand Binding by an αIIb Peptide that Clasps the Hybrid Domain to the βI Domain of β3.

Authors:  Wen Hwa Lee; Elisabeth Schaffner-Reckinger; Demokritos C Tsoukatos; Kelly Aylward; Vassilios Moussis; Vassilios Tsikaris; Paraskevi Trypou; Marion Egot; Dominique Baruch; Nelly Kieffer; Christilla Bachelot-Loza
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.